Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.947 EUR
197.84 M EUR
946.46 M EUR
78.36 M
About BAVARIAN NORDIC A/S
Sector
CEO
Paul Chaplin
Headquarters
Hellerup
Website
Founded
1992
ISIN
DK0015998017
FIGI
BBG00LJSB7H5
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange BAVARIAN NORDIC stocks are traded under the ticker BV3.
We've gathered analysts' opinions on BAVARIAN NORDIC future price: according to them, BV3 price has a max estimate of 49.59 EUR and a min estimate of 31.90 EUR. Watch BV3 chart and read a more detailed BAVARIAN NORDIC stock forecast: see what analysts think of BAVARIAN NORDIC and suggest that you do with its stocks.
Yes, you can track BAVARIAN NORDIC financials in yearly and quarterly reports right on TradingView.
BAVARIAN NORDIC is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
BV3 earnings for the last quarter are 0.32 EUR per share, whereas the estimation was 0.70 EUR resulting in a −53.89% surprise. The estimated earnings for the next quarter are 1.15 EUR per share. See more details about BAVARIAN NORDIC earnings.
BAVARIAN NORDIC revenue for the last quarter amounts to 178.26 M EUR, despite the estimated figure of 225.11 M EUR. In the next quarter, revenue is expected to reach 272.50 M EUR.
BV3 net income for the last quarter is 9.45 M EUR, while the quarter before that showed 34.94 M EUR of net income which accounts for −72.95% change. Track more BAVARIAN NORDIC financial stats to get the full picture.
No, BV3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 27, 2024, the company has 1.38 K employees. See our rating of the largest employees — is BAVARIAN NORDIC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAVARIAN NORDIC EBITDA is 236.11 M EUR, and current EBITDA margin is 29.07%. See more stats in BAVARIAN NORDIC financial statements.
Like other stocks, BV3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAVARIAN NORDIC stock right from TradingView charts — choose your broker and connect to your account.